King Minos hall III
King Minos hall III
Clinical Nephrology
N.3B. Renal dietetics
1. TBC
2. TBC
3. TBC
A. Γόμπου, Δ. Κιρμιζής
Β. Σταθόπουλος
N.3B. Renal dietetics
1. TBC
2. TBC
3. TBC
Χ. Πολίτης
Ν. Γιτσαρά
Διαλειμμα - Καφές
Cardiovascular morbidity
N.7A. Haemodialysis
1. Uremic pruritus: systematic review, evaluation and management Olga Ellina
2. Response to ultrafiltration in dialysis Nikolaos Mitsides
3. Management of the patient with diabetes on dialysis Irini Vasiliou
Π. Μανωλακάκη
Γ. Βολιώτης
TBC
Β. Ράπτης, Β. Ράϊκου
Διαλειμμα - Γεύμα
Cardiovascular morbidity
N.4A. IgA nephropathy
1. The role of B cells and BAFF/APRIL Dimitrios Bakoulis
2. New and emerging therapies in IgA nephropathy Panagiotis Kompotiatis
3. How should I manage the patient with IgA nephropathy Maria Stangou
Θ. Χήρας, Β. Αθανασιάδου
Θ. Χήρας
Γ. Μυσερλής
Cardiovascular morbidity
Ε. Ιντζεβίδου
Ι. Δρούλιας
N.6A. Hypertension
1. Management of hypertension in patients with CKD Georgios Hatzivasiliou
2. Resistant hypertension Vasileios Raptis
3. Use of diuretics in CKD: benefits and risks Eleni Intzevidou
4. Hypertension in dialysis Antonios Zagorianakos
Ο. Κουγιουμτζίδου, Η. Κυρίτσης
Cardiovascular morbidity
Διαλειμμα - Καφές
General assembly
Cardiovascular morbidity
Π. Νέννες, Δ. Κιρμιζής
N.3A. Cardiovascular morbidity in CKD
1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias
2. HIF inhibitors: their place in clinical practice Athena Gompou
3. Update in the management of hyperkalaemia Evdokia Efthymiou
Ο. Κουγιουμτζίδου
Δ. Μωϋσιάδης
Ε. Σταυρινού
Close
Approved by:
Participants:
Participants:
